Soleno Therapeutics, Inc. (SLNO) Q4 2018 Earnings Results

Soleno Therapeutics Misses on Revenue, Stock Down 3.73%

Soleno Therapeutics reported an EPS of $0.02, but there was no revenue data available. The stock reacted negatively, dropping 3.73%, indicating investor uncertainty or disappointment despite the EPS figure.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.02	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on numerical results.

Soleno Therapeutics Misses on Revenue, Stock Down 3.73%

Key numbers

Management commentary

Soleno Therapeutics, Inc.

More earnings this week

Soleno Therapeutics Misses on Revenue, Stock Down 3.73%

Key numbers

Management commentary